Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
Indivior Pharmaceuticals, Inc. EPS 2022–2025
Indivior Pharmaceuticals, Inc. annual/quarterly eps history and growth rate from 2022 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Indivior Pharmaceuticals, Inc. eps for the quarter ending March 31, 2026 was $0.69, a 81.58% increase year-over-year.
- Indivior Pharmaceuticals, Inc. annual eps for 2025 was $1.64, a 3180.00% increase from 2024.
- Indivior Pharmaceuticals, Inc. annual eps for 2024 was $0.05, a 105.43% decrease from 2023.
- Indivior Pharmaceuticals, Inc. annual eps for 2023 was $0.92, a 187.50% increase from 2022.
- Indivior Pharmaceuticals, Inc. annual eps for 2022 was $0.32.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Indivior Pharmaceuticals, Inc. EPS — FAQ
Indivior Pharmaceuticals, Inc. (INDV) eps over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Indivior Pharmaceuticals, Inc.'s eps?
Indivior Pharmaceuticals, Inc. (INDV) reported eps of $1.64 for fiscal 2025.
Where can I see INDV's eps history?
The chart and table above show Indivior Pharmaceuticals, Inc.'s eps by year and by quarter, including the growth rate.